Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 11, 2019

View Archived Issues

Killer T cells protected by membrane lipid order and charge

Enterovirus contributes to islet autoimmunity

CARsgen Therapeutics receives IND clearance for AB-011 in China

Scohia Pharma initiates phase I study of SCO-267

IND for HLX-10 plus HLX-07 antibody combination therapy approved in China

FDA clears IND application for first-in-human study of CPT-31

Intrathecal AVXS-301 shows promise in preclinical models of ALS

Implicit Bioscience presents phase I data for IC-14 in motor neuron disease

Anti-BCMA CAR-T candidate C-CAR088 shows early clinical efficacy

Pfizer gives details on the discovery of novel noncovalent modulator of hemoglobin

First-in-human study of LOXO-305 confirms it as a potent anti-BTK agent for B-cell malignancies

The anti-CD33/CD3 BiTE AMG-673 shows promise as treatment for relapsed/refractory AML

GenSight reports on REALITY registry study in support of Lumevoq

Three phase III trials of tralokinumab in atopic dermatitis meet endpoints

Xeris reports in-clinic stage data from phase II trial of RTU glucagon

Constellation Pharmaceuticals patents EZH2 inhibitors

Primmune Therapeutics discloses new TLR7 agonists

VenatoRx Pharmaceuticals patent details bacterial PBP3 inhibitors

Alligator initiates first-in-human study of 4-1BB antibody ATOR-1017

University of Texas System identifies KRAS-targeting compounds

hSTING agonists described in Incyte patent

Iterum reports topline data from phase III trial of sulopenem in cIAI

EicOsis initiates phase I trial of sEH inhibitor EC-5026 for pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...